WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone. Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic. Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid. The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity. |
British fatherFierceness is 5Taxpayers could be on the hook for a multiChris Brady has 5 saves to help Fire play Atlanta to 0Zhang Yufei bags fourth gold in China's national swimming championshipsGuangdong into playoffs semis, oust ZhejiangConservative MP Dan Poulter defects to Labour in the latest blow to Rishi SunakDevastating footage shows horrific aftermath of tornadoes that barreled through Nebraska and IowaEMILY PRESCOTT: Did King Charles's exTaxpayers could be on the hook for a multi